OptimizeRx Corp 2026 SR
The report outlines OptimizeRx's environmental, social, and governance initiatives and performance for the fiscal year 2025. The company expanded its greenhouse gas emissions reporting to include Scope 3 emissions alongside Scope 1 and Scope 2 emissions for all office locations in the United States and Croatia. OptimizeRx highlights its commitment to data privacy and security, maintaining SOC 2 Type 1 and Type 2 certifications. Additionally, the company emphasizes its focus on talent acquisition, pay equality, and corporate governance, aligning its metrics with the World Economic Forum's core ESG pillars.
Company: OptimizeRx Corp
Sector: Health Care
Country: United States
Year: 2026
Type: SR
Pages: 41
OptimizeRx Corp
Environmental, Social, And Governance (ESG) Report
The report outlines OptimizeRx's environmental, social, and governance initiatives and performance for the fiscal year 2025. The company expanded its greenhouse gas emissions reporting to include Scope 3 emissions alongside Scope 1 and Scope 2 emissions for all office locations in the United States and Croatia. OptimizeRx highlights its commitment to data privacy and security, maintaining SOC 2 Type 1 and Type 2 certifications. Additionally, the company emphasizes its focus on talent acquisition, pay equality, and corporate governance, aligning its metrics with the World Economic Forum's core ESG pillars.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2026
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Women in Management
Workplace Fatalities
Employees